Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Post-transplant adoptive T-cell immunotherapy Aqui NA; June CHBest Pract Res Clin Haematol 2008[Sep]; 21 (3): 503-19Immune reconstitution following haematopoietic stem cell transplantation (SCT) is an often slow and incomplete process that leads to increased risk of infection and malignant disease. Immunization in SCT is frequently unsuccessful due to the prolonged lymphopenia, especially of CD4 T cells, seen following transplant. The transfusion of T cells, also called 'adoptive T-cell therapy', has the potential to enhance anti-tumour and overall immunity, and augment vaccine efficacy in the post-transplant setting. Recent advances in tissue culture, cellular immunology and tumour biology are guiding new approaches to adoptive T-cell therapy. This chapter will discuss the challenges that face the field before adoptive T-cell therapy can be translated into routine clinical practice.|*Immunotherapy, Adoptive/adverse effects[MESH]|Adoptive Transfer/methods[MESH]|CD4-Positive T-Lymphocytes/immunology/transplantation[MESH]|CD8-Positive T-Lymphocytes/immunology/transplantation[MESH]|Hematopoietic Stem Cells/*immunology[MESH]|Humans[MESH]|Immunologic Deficiency Syndromes/etiology[MESH]|Lymphocyte Depletion[MESH]|Stem Cell Transplantation/adverse effects/methods[MESH]|T-Lymphocytes/*immunology/*transplantation[MESH]|Transplantation, Homologous[MESH] |